Jsc Nextgen
Clinical trials sponsored by Jsc Nextgen, explained in plain language.
-
Gene therapy trial aims to heal scarred bladders in painful condition
Disease control Recruiting nowThis study is testing whether a gene therapy called Neovasculgen can help women with a severe form of interstitial cystitis, a painful bladder condition. The goal is to see if the treatment can reduce scarring caused by standard procedures and prevent the bladder from shrinking. …
Phase: PHASE2, PHASE3 • Sponsor: JSC NextGen • Aim: Disease control
Last updated Apr 02, 2026 04:12 UTC
-
Gene therapy trial offers hope for chronic bladder pain sufferers
Disease control Recruiting nowThis study is testing whether a gene therapy called Neovasculgen can help women with painful bladder syndrome. Researchers want to see if it reduces pelvic pain and frequent urination while also preventing the bladder from shrinking. The trial will compare the gene therapy agains…
Phase: PHASE2, PHASE3 • Sponsor: JSC NextGen • Aim: Disease control
Last updated Apr 02, 2026 04:11 UTC
-
New drug trial aims to heal diabetic foot wounds
Disease control Recruiting nowThis study is testing if a drug called Neovasculgen, given as injections, can help heal foot ulcers in people with diabetes. It will compare the drug against a placebo (inactive substance) in 144 patients who have a non-healing ulcer. The main goal is to see if more patients achi…
Phase: PHASE3 • Sponsor: JSC NextGen • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC